Non-specific supersensitivity of striatal dopamine receptors after 6-hydroxydopamine lesion of the nigrostriatal pathway
- PMID: 942921
- DOI: 10.1016/0014-2999(76)90229-6
Non-specific supersensitivity of striatal dopamine receptors after 6-hydroxydopamine lesion of the nigrostriatal pathway
Abstract
6-Hydroxydopamine (6-OHDA) was injected unilaterally into the area of the ascending dopamine pathways in the lateral hypothalamus. Rats immediately developed spontaneous ipsilateral circling which was enhanced by d-amphetamine (0.63-2.5 mg/kg i.p.) and reversed to a contralateral response by apomorphine (0.015-0.5 mg/kg s.c.). These effects were maximal by the 8th postoperative day. At a time when circling responses were established and biochemical determinations showed striatal dopamine levels to be reduced by at least 80% (limbic dopamine depleted by 60%, telencephalic noradrenaline by 35% but no reductions in 5-hydroxytryptamine), the injection of dopamine (50, 100 mug) and apomorphine (12.5, 25 mug) into the striatum ipsilateral to the 6-OHDA lesion induced contralateral circling/asymmetries. These effects were of lower intensity or absent in non-lesioned rats but a consistent increase in potency of dopamine after 6-OHDA could not be demonstrated. However, similar injections of 5-hydroxytryptamine and noradrenaline, which are completely inactive in normal rats, caused more marked contralateral asymmetries/circling at lower intrastriatal doses than dopamine (5-hydroxytryptamine 25-100 mug, noradrenaline 6.25-100 mug). Dyskinesias of the contralateral forelimb were induced by unilateral intrastriatal dopamine (100 mug) in a small proportion of non-lesioned rats: the effects were enhanced when dopamine (50-100 mug) was injected into the striatum ipsilateral to a 6-OHDA lesion. Both potency and intensity of effect were enhanced. Noradrenaline (25-100 mug) also induced contralateral dyskinesias in the 6-OHDA-lesioned rats although similar injections were inactive in non-lesioned rats. 5-Hydroxytryptamine was inactive in this effect in both groups of rats. It is suggested that after 6-OHDA lesion of the nigrostriatal pathway striatal dopamine receptors may change both their sensitivity and specificity.
Similar articles
-
The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain.Brain Res. 1976 Dec 10;118(1):87-113. doi: 10.1016/0006-8993(76)90843-x. Brain Res. 1976. PMID: 990957
-
Circling behavior in rats with 6-hydroxydopamine or electrolytic nigral lesions,Eur J Pharmacol. 1976 Jun;37(2):339-56. doi: 10.1016/0014-2999(76)90042-x. Eur J Pharmacol. 1976. PMID: 986305
-
Does contralateral circling involve action of drugs on hyposensitive striatal dopamine receptors in the hemisphere contralateral to denervation?Neuropharmacology. 1983 Mar;22(3):295-302. doi: 10.1016/0028-3908(83)90243-5. Neuropharmacology. 1983. PMID: 6133233
-
6-hydroxydopamine-induced degeneration of the nigrostriatal dopamine pathway: the turning syndrome.Pharmacol Ther B. 1976;2(1):37-40. doi: 10.1016/0306-039x(76)90016-7. Pharmacol Ther B. 1976. PMID: 772721 Review. No abstract available.
-
Antiparkinsonian drugs and dopaminergic neostriatal mechanisms: studies in rats with unilateral 6-hydroxydopamine (=6-OH-DA)-induced degeneration of the nigro-neostriatal DA pathway and quantitative recording of rotational behaviour.Pharmacol Ther B. 1976;2(1):41-7. doi: 10.1016/0306-039x(76)90017-9. Pharmacol Ther B. 1976. PMID: 817332 Review. No abstract available.
Cited by
-
Evaluation of the integrity of the dopamine system in a rodent model of Parkinson's disease: small animal positron emission tomography compared to behavioral assessment and autoradiography.Mol Imaging Biol. 2006 Sep-Oct;8(5):292-9. doi: 10.1007/s11307-006-0051-6. Mol Imaging Biol. 2006. PMID: 16897319
-
Unilateral striatal dopamine denervation: reduced motor inhibitory effects of dopamine antagonists revealed in models of asymmetric and circling behaviour.Naunyn Schmiedebergs Arch Pharmacol. 1984 May;326(1):29-35. doi: 10.1007/BF00518775. Naunyn Schmiedebergs Arch Pharmacol. 1984. PMID: 6433208
-
Reward prediction error does not explain movement selectivity in DMS-projecting dopamine neurons.Elife. 2019 Apr 4;8:e42992. doi: 10.7554/eLife.42992. Elife. 2019. PMID: 30946008 Free PMC article.
-
Designing Functionally Selective Noncatechol Dopamine D1 Receptor Agonists with Potent In Vivo Antiparkinsonian Activity.ACS Chem Neurosci. 2019 Sep 18;10(9):4160-4182. doi: 10.1021/acschemneuro.9b00410. Epub 2019 Aug 20. ACS Chem Neurosci. 2019. PMID: 31387346 Free PMC article.
-
Further evidence for two directions of D-1:D-2 dopamine receptor interaction revealed concurrently in distinct elements of typical and atypical behaviour: studies with the new enantioselective D-2 agonist LY 163502.Psychopharmacology (Berl). 1989;98(2):245-50. doi: 10.1007/BF00444699. Psychopharmacology (Berl). 1989. PMID: 2569218
MeSH terms
Substances
LinkOut - more resources
Full Text Sources